ArticleJournal of shoulder and elbow arthroplasty2026
Outcomes of reverse total shoulder arthroplasty in patients ≤65 years old.
Article in Journal of shoulder and elbow arthroplasty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Reverse total shoulder arthroplasty (rTSA) is growing in popularity due to advancements in implant design, improvements in surgical techniques, and expanded indications. Hesitancy to perform rTSA in younger patients is due to concerns regarding implant longevity and functional outcomes. This study investigates outcomes of rTSA in patients ≤65 years old in the largest known cohort to date. Methods: Patients who underwent rTSA by 3 surgeons (C.M.J., M.L.K., W.N.L.) from 2014 to 2025 were retrospectively identified. Exclusion criteria were >65 years old, prior rTSA, and <12 months follow-up. Patient demographics, complications, and clinical outcomes were collected. Results: One hundred three patients were included. The average age was 59.5 ± 6.5 years and the average follow-up duration was 31.4 ± 27.2 months. Fifty six percent of patients had prior ipsilateral shoulder surgery. The most common diagnosis was cuff tear arthropathy (62.1%). Pre-operatively, 93.2% patients were independent. Post-operatively, 58.3% of patients were discharged the same day and 98.1% of patients went home. Pre-operative forward flexion was 81 ± 48°, external rotation at the side (ER side) was 16 ± 22°, ER at 90° abduction ER 90°) was 53 ± 24°, and internal rotation (IR) was L5. At 2-years post-operatively, forward flexion improved to 146 ± 20 ( Conclusion: rTSA can reliably improve clinical outcomes in patients ≤65 years old. Overall, complication rates are low despite most patients having had prior ipsilateral shoulder surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.